2018 American Transplant Congress » Poster Session A: Kidney Transplant Goes Viral

Date: Saturday, June 2, 2018

Time: 5:30pm-7:30pm

Location: Hall 4EF

Session Type: Poster Session

Meeting: 2018 American Transplant Congress

5:30pm-7:30pm: Association of Tacrolimus Adherence and Discontinuation with Sepsis Risk among Kidney Transplant Recipients

J. Donnelly,¹ P. MacLennan,¹ R. Mannon,¹ R. Saran,² J. Baddley,¹ H. Wang,³ G. McGwin, Jr.,¹ P. Muntner.¹

5:30pm-7:30pm: Brincidofovir for Disseminated Adenovirus in Kidney and Kidney-Pancreas Transplant Recipients: Report of a Case Series

L. Bowman, R. Baliga, C. Mayer.

5:30pm-7:30pm: Burden of Primary CMV Infections Remains High Despite Six Months Valganciclovir Prophylaxis in High-Risk Kidney Transplant Recipients

I. Helanterä,¹ F. Ortiz,² R. Loginov,³ L. Mannonen,³ M. Lempinen,¹ I. Lautenschlager.³

5:30pm-7:30pm: Cause of ESRD is Not Associated with Risk of Post-Transplant CMV Infection

S. Panzer, S. Peery, B. Astor, A. Djamali, T. Singh.

5:30pm-7:30pm: Clinical Outcomes of Kidney Transplant Recipients Infected with Hepatitis C Virus and Treated with Direct-Acting Antiviral Therapy

M. Alkadi,¹ E. Abuhelaiqa,¹ M. Derbala,² O. Fituri,¹ J. Mahmoud,³ M. Jarman,³ M. Asim,¹ A. Aziz,¹ A. Nauman,¹ A. Hamdi,¹ Y. Medhat,² S. Al Kaabi,² H. Al-Malki.¹

5:30pm-7:30pm: Clinical Significance of BK Virus-Specific ELISPOT Assay in Kidney Transplant Recipients

J. Chang,^1,2 H. Bae,³ K. Park,³ H. Lee,³ B. Choi,^1,2 C. Park,^1,2 C. Yang,^1,2 Y. Kim,^1,2 E-.J. Oh,^1,4 B. Chung.^1,2

5:30pm-7:30pm: Clinical Validation of a Novel ELISpot-Based In Vitro Diagnostic Assay to Monitor CMV-Specific Cell-Mediated Immunity in Kidney Transplant Recipients

B. Banas,¹ D. Steubl,² L. Renders,² D. Chittka,¹ M. Banas,¹ T. Wekerle,³ M. Koch,⁴ O. Witzke,⁵ A. Muehlfeld,⁶ C. Sommerer,⁷ A. Habicht,⁸ C. Hugo,⁹ T. Huenig,¹⁰ M. Lindemann,⁵ T. Schmidt,¹¹ A. Rascle,¹¹ S. Barabas,¹¹ L. Deml,¹¹ R. Wagner,^1,11 B. Kraemer,¹² B. Krueger.¹²

5:30pm-7:30pm: Cryptococcal Infections in Kidney Transplant Recipients. A Single Center Experience

M. Radisic,¹ N. Pujato,¹ A. Dotta,² R. Livia Franzini,² M. Bravo,¹ L. Rodriguez Rilo,¹ C. Giampieri,² L. Leon,¹ M. Rial,¹ D. Casadei.¹

5:30pm-7:30pm: Do We Need to Worry about EBV DNAemia in the Late Post-Transplant Period?

M. Morton,¹ K. Daga,² P. Klapper,² M. Picton,¹ P. Vallely.²

5:30pm-7:30pm: Early Infectious Outcomes of Older Adults Undergoing Kidney Transplantation (KT). A Case Control Study

M. Hemmersbach-Miller,^1,2 K. Schmader.³

5:30pm-7:30pm: Effect of Influenza Vaccine in Patients with Kidney Transplant

K. Tsujimura,¹ M. Ota,¹ H. Ishida,² K. Tanabe.²

5:30pm-7:30pm: Evaluation of Allergy to Tacrolimus in Kidney Transplant Candidates and Recipients with a History of Macrolide Antibiotic Allergy

J. Trofe-Clark,^1,2 M. Doshi,³ O. Fadugba,⁴ M. Lim.²

5:30pm-7:30pm: Fosfomycin vs Other Antibiotics for UTI after Kidney Transplant

O. Mgbako,¹ J-.E. Ha,¹ N. Topilow,² E. Min,¹ D. Taupin,¹ V. Tatapudi,¹ B. Gelb,¹ S. Hochman.¹

5:30pm-7:30pm: Impact of Pneumocystis Prophylaxis on Incidence of Treated Urinary Tract Infections Following Kidney Transplantation

S. Sanchez, M. Brokhof, N. Kenyon, C. Varughese, N. Alvey.

5:30pm-7:30pm: Long-Term Outcome of Kidney Transplant Recipient with HTLV-1 Infection

N. Goto,¹ M. Minami,¹ K. Futamura,² M. Okada,¹ M. Tsujita,¹ T. Hiramitsu,² S. Narumi,² Y. Watarai.²

5:30pm-7:30pm: Opportunistic Infections after Kidney Transplantation Are Independent Risk Factor of Kidney Allograft Loss: A Retrospective Cohort Study

P. Attias,¹ G. Melica,² E. Audureau,³ D. Boutboul,⁵ N. De Castro,⁴ S. Gallien,² P. Grimbert,¹ M. Matignon.¹

5:30pm-7:30pm: Outcomes of Kidney Transplantation from HBsAg Positive Donors to HBsAb Positive Recipients

G. Chen, C. Wang, Z. Wu, X. Liu, C. Wang, L. Chen.

5:30pm-7:30pm: Outpatient Prophylactic Valganciclovir Dose Optimization Post-Renal Transplant

M. Spinner,¹ V. Athans,¹ C. Koval.²

5:30pm-7:30pm: Prevention of Hepatitis B Virus Reactivation in HBsAg-Positive Renal Transplant Recipients with Rituximab Treatment

J. Choi, J. Jung, H. Kwon, S. Shin, Y. Kim, D. Han.

5:30pm-7:30pm: Recovery of Wild-Type Genotype after Documented Ganciclovir-Resistance in Transplant Recipients with Recurrent CMV Viremia

J. Fose, M. Jorgenson, Z. Degrave, R. Redfield, J. Smith, D. Mandelbrot.

5:30pm-7:30pm: Relation between Seroprevalence of Cytomegalovirus and Graft Survival in Japanese Kidney Transplant Recipients: The Japan Academic Consortium of Kidney Transplantation Study

K. Miyake,^1,2 M. Okumi,¹ K. Unagami,³ Y. Kakuta,¹ H. Shirakawa,⁴ K. Omoto,⁵ H. Ishida,¹ K. Tanabe.¹

5:30pm-7:30pm: Retrospective Study of Cryptococcosis in Kidney Transplant Recipients from a Single Center

R. Wang, M. Cen, J. Lin, H. Huang, W. Peng, J. Wu.

5:30pm-7:30pm: Single-Center Experience with Sofosbuvir-Based HCV Treatment after Kidney Transplantation

V. Garcia, G. Meinerz, C. da Silva, R. Bruno, E. Keitel.

5:30pm-7:30pm: Standard- versus Low-Dose Valganciclovir for Cytomegalovirus Prophylaxis in Intermediate-Risk Kidney Transplant Recipients

N. Wilson, N. Sulejmani, A. Jantz, A. Patel, B. Summers.

5:30pm-7:30pm: The Effects of Pre-Transplant Pyuria of the Deceased Donor on Post-Transplant Urinary Tract Infections in the Case of Gender Mismatch Transplantation

Y. Kim,¹ S. Park.²

5:30pm-7:30pm: Transplant Tourism and Invasive Fungal Infection

F. Al Ismaili,¹ A. Metry,³ M. Al Riyami,⁵ F. Khamis,⁶ F. Shaheen,⁷ A. Hola,⁴ I. Al Salmi.²

5:30pm-7:30pm: Tuberculosis among Kidney Transplant Patients Compared to Dialysis and Non-Dialysis CKD Patients over a Decade Period

A. Metry, I. Al Salmi, F. Al Ismaili, A. Hola, F. Shaheen, I. Al Salmi.

5:30pm-7:30pm: Using Machine Learning and Simulation to Compare High Risk Kidney Transplant Survival to Waiting for a Non High Risk Organ

E. Mark, D. Goldsman, P. Keskinocak, B. Gurbaxani.

« View all sessions from the 2018 American Transplant Congress